Sign In
Buy ICLR
$142.67
+1.94 (+1.38%)
At Close: Jun 23, 2026
Icon PLC (ICLR) Soars 4.5%: Is Further Upside Left in the Stock?
07:34am, Friday, 16'th Apr 2021
Icon PLC (ICLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
5 Health Care Stocks Boosting Earnings
11:42am, Wednesday, 31'st Mar 2021
The following health care companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of March 31, all of them also trade with
Icon PLC (ICLR) Surges 4.6%: Is This an Indication of Further Gains?
07:35am, Monday, 08'th Mar 2021
Icon PLC (ICLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ICON Public Limited Company (ICLR) CEO Steve Cutler on Q4 2020 Results - Earnings Call Transcript
04:29am, Sunday, 28'th Feb 2021
ICON Public Limited Company (ICLR) CEO Steve Cutler on Q4 2020 Results - Earnings Call Transcript
ICON (ICLR) To Buy PRA Health Sciences (PRAH) In $12 Billion Deal
08:02am, Thursday, 25'th Feb 2021
ICON plc, (NASDAQ: ICLR) recently announced it entered into a definitive agreement to acquire PRA Health Sciences, Inc. (NASDAQ: PRAH) in a deal valued at $12 billion. These are the details.
PRA HEALTH SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRAH and Encourages Investors to Contact the Firm
12:09pm, Wednesday, 24'th Feb 2021
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PRA Health
Icon PLC (ICLR) Surpasses Q4 Earnings and Revenue Estimates
08:21am, Wednesday, 24'th Feb 2021
Icon PLC (ICLR) delivered earnings and revenue surprises of 3.83% and 1.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
ICON Reports Fourth Quarter and Full Year 2020 Results
06:01am, Wednesday, 24'th Feb 2021
DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2020 Results
ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research
06:00am, Wednesday, 24'th Feb 2021
DUBLIN--(BUSINESS WIRE)--ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research
ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support
04:30am, Monday, 08'th Feb 2021
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the r
ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference
04:15pm, Thursday, 07'th Jan 2021
DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference
ICON Supports Pfizer and BioNTech on the Investigational COVID-19 Vaccine Trial
04:15am, Monday, 04'th Jan 2021
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device ind
ICON Plc -- Moody's affirms Baa3 issuer rating of ICON Plc, stable outlook
05:30pm, Thursday, 30'th Jul 2020
Moody's Investors Service, ("Moody's") has today affirmed the Baa3 long term issuer rating of ICON Plc ("ICON" or "the company"). ICON is strongly positioned in the Baa3 rating. Additionally, Moody'
Icon PLC: A CRO Momentum Stock Worth Backing Long Term
11:45am, Wednesday, 29'th Jul 2020
Icon is a contract research organisation specialising in conducting clinical trials for biotechs and big pharma.
ICON Public Limited Company (ICLR): Were Hedge Funds Right About This Stock?
12:29am, Tuesday, 28'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
